Selective Laser Trabeculoplasty (SLT) is a minimally invasive, laser-based procedure used to treat open-angle glaucoma, one of the leading causes of irreversible blindness. Unlike traditional glaucoma surgeries, SLT works by using low-energy laser pulses to stimulate the eye’s natural drainage system, helping to reduce intraocular pressure (IOP) without damaging surrounding tissue.
Approved by the FDA in 2001, SLT has gained popularity due to its high success rates, minimal downtime, and repeatable nature. It’s often recommended when eye drops aren’t effectively controlling eye pressure or if patients struggle with medication side effects. Many ophthalmologists consider SLT a first-line treatment for early to moderate glaucoma because of its safety and effectiveness.
If you’ve been diagnosed with glaucoma or are exploring alternatives to daily eye drops, SLT could be a life-changing option. This guide will cover everything you need to know—from how it works to recovery and long-term benefits.
Selective Laser Trabeculoplasty (SLT) targets the trabecular meshwork, a tiny drainage system in the eye responsible for regulating fluid outflow. When this meshwork becomes clogged or inefficient, fluid builds up, increasing intraocular pressure (IOP) and damaging the optic nerve—leading to glaucoma.
SLT uses a specialized Q-switched Nd:YAG laser that delivers short, low-energy pulses to the trabecular meshwork. Unlike older laser treatments (like ALT), SLT is "selective"—it only affects specific pigmented cells while leaving surrounding tissue intact. This stimulates a biochemical response that improves drainage, lowering eye pressure naturally.
The entire procedure takes just 5-10 minutes per eye and is performed in an outpatient setting. Since SLT doesn’t involve incisions or implants, the risk of complications is significantly lower than with traditional glaucoma surgeries. Many patients experience noticeable pressure reduction within 4-6 weeks, with effects lasting months or even years.
SLT isn’t for everyone, but it’s an excellent option for many glaucoma patients. Ideal candidates include:
However, SLT may not be suitable for people with:
An ophthalmologist will evaluate your eye health, medical history, and glaucoma severity to determine if SLT is right for you.
Wondering what to expect during an SLT procedure? Here’s a detailed breakdown:
The entire process is painless and completed in under 15 minutes. Most patients resume normal activities the same day, though some may experience mild blurriness or sensitivity to light for a few hours.
Compared to traditional glaucoma treatments, SLT offers several key benefits:
While SLT isn’t a cure for glaucoma, it’s a powerful tool to manage the disease with fewer hassles than daily medications or major surgery.
SLT is considered very safe, but like any medical procedure, it carries some risks:
Serious complications (like infection or permanent vision loss) are extremely rare with SLT compared to traditional glaucoma surgeries. Your ophthalmologist will discuss all risks during your consultation.
One of SLT’s biggest advantages is its easy recovery. Here’s what to expect:
Most patients see pressure reduction within 4-6 weeks. If results diminish over time (typically after 1-5 years), SLT can often be repeated.
Most patients feel only minor discomfort, similar to a tiny flick on the eye. Numbing drops prevent significant pain.
Effects typically last 1-5 years. Some patients maintain low pressure for over a decade; others may need a repeat treatment sooner.
No—SLT manages glaucoma by lowering eye pressure but doesn’t reverse optic nerve damage. Ongoing monitoring is essential.
Most U.S. insurance plans (including Medicare) cover SLT when medically necessary. Check with your provider for details.